Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.62B
Enterprise Value2.99B
P/E Ratio-10.89
PEG Ratio0.1
Price/Sales Ratio6.06
Price/Book Ratio1.43
Enterprise/Revenue5.72
Enterprise/EBITDA-13.81

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.55
Operating Margin-0.56
AD

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.13

Income Statement

Revenue541.45M
Revenue/Share3.76
Gross Profit230.88M
EBITDA-140.03M
Net Income-231.27M
Diluted EPS-1.77

Balance Sheet

Total Cash823.92M
Total Cash/Share6.29
Total Debt33.08M
Total Debt/Equity0.02
Current Ratio4.36
Book Value Per Share15.97

Price History

52-Week Change-43.47
52-Week High50.68
52-Week Low22.4
Moving Average 50 Days26.86
Moving Average 200 Days30.5

Statistics

Average Volume7.87M
Shares Outstanding130.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split FactorN/A
Last Split DateN/A
AD